Cargando…
New Amino Naphthoquinone Derivatives as Anti-Trypanosoma cruzi Agents Targeting Trypanothione Reductase
To develop novel chemotherapeutic alternatives for the treatment of Chagas disease, in this study, a set of new amino naphthoquinone derivatives were synthesised and evaluated in vitro on the epimastigote and trypomastigote forms of Trypanosoma cruzi strains (NINOA and INC-5) and on J774 murine macr...
Autores principales: | Espinosa-Bustos, Christian, Ortiz Pérez, Mariana, Gonzalez-Gonzalez, Alonzo, Zarate, Ana María, Rivera, Gildardo, Belmont-Díaz, Javier A., Saavedra, Emma, Cuellar, Mauricio A., Vázquez, Karina, Salas, Cristian O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228152/ https://www.ncbi.nlm.nih.gov/pubmed/35745694 http://dx.doi.org/10.3390/pharmaceutics14061121 |
Ejemplares similares
-
In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-N-oxide Derivatives against Trypanosoma cruzi as Trypanothione Reductase Inhibitors
por: González-González, Alonzo, et al.
Publicado: (2022) -
Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi()
por: Jones, Deuan C., et al.
Publicado: (2010) -
Investigation of Trypanothione Reductase as a Drug Target in Trypanosoma brucei
por: Spinks, Daniel, et al.
Publicado: (2009) -
Relevance of Trypanothione Reductase Inhibitors on Trypanosoma cruzi Infection: A Systematic Review, Meta-Analysis, and In Silico Integrated Approach
por: Mendonça, Andréa Aparecida Santos, et al.
Publicado: (2018) -
In Silico Exploration of the Trypanothione Reductase (TryR) of L. mexicana
por: Barrera-Téllez, Francisco J., et al.
Publicado: (2023)